论文部分内容阅读
本文旨在探讨检测支气管肺泡灌洗液(BALF)中CEA、CYFRA21—1水平对肺癌的诊断价值。 资料和方法 一、临床资料:肺癌组32例(男26,女6),年龄43～86岁,平均63岁。均经胸片、胸部CT、纤支镜检查确诊并有病理检查证实。其中鳞癌7例,腺癌6例,肺泡细胞癌1例,鳞腺癌2例,不定型16例。对照组30例(男18,女12),年龄43～71岁,平均58岁,为同期住院病人,亦经胸片、胸部CT、纤支镜检查确诊。其中支气管扩张伴咯血12例,肺炎6例,间质性肺炎2例,支气管炎6例,肺结核1例,慢支咯血3例。
This article aims to explore the diagnostic value of detecting CEA and CYFRA21-1 levels in bronchoalveolar lavage fluid (BALF) for lung cancer. Materials and Methods First, clinical data: 32 patients with lung cancer (male 26, female 6), aged 43 to 86 years old, average 63 years old. All patients were diagnosed with chest X-ray, chest CT, fiber bronchoscopy, and confirmed by pathological examination. There were 7 cases of squamous cell carcinoma, 6 cases of adenocarcinoma, 1 case of alveolar cell carcinoma, 2 cases of squamous adenocarcinoma, and 16 cases of adenocarcinoma. In the control group, 30 patients (male 18, female 12) aged 43-71 years old (mean 58 years old) were hospitalized patients during the same period and were confirmed by chest radiograph, chest CT, and bronchoscopy. There were 12 cases of bronchiectasis with hemoptysis, 6 cases of pneumonia, 2 cases of interstitial pneumonia, 6 cases of bronchitis, 1 case of pulmonary tuberculosis, and 3 cases of chronic bronchitis.